Please email us at [email protected] with our item No, NDC#, UPC# or the product link if you have any quetions. We are located in Oceanside, California. Search over 110,000 items by Name, Item No., NDC, UPC (without dashes) or by Mfg.Name. Please note, Prescription items can only be ordered by a Drug Manufacturer, Wholesaler, Hospital, Governmental Medical Facility, VA, Pharmacy, Physician, Physician Assistant, Nurse Practitioner, Dentist, Podiatrist, Optometrist, Veterinarian, Naturopath, Licensed Lab, Physical Therapist & Pharmacist in their scope of practice. No order will ship, unless you you have provided us the Medical License (and DEA Lic. in case of controlled drug) and we had verified that. Rx items can only be shipped to AZ, AR, CA, CT, DE, FL, GA, GU, HI, IL, KS, KY, LA, ME, MA, MI, NJ, NY, PA, PR, TX, TN, VA, WA, WI and WV. If you are an International Physician or Pharmacist, please contact us before ordering.


Menu

Rx Item-Abrilada (adalimumab-afzb) Injection by Pfizer �Single-Dose Institutiona

RX00069-0319-01Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Rx Item-Abrilada (adalimumab-afzb) Injection by Pfizer �Single-Dose Institutiona

$0.00

Abrilada-Single-Dose Institutional Use Vial Carton - 40 mg/0.8 mL NDC No.00069031901 00069-0319-01 0069-0319-01 0069031901 00069031901 UPC/GTIN No.3-00690-31901-8 300690-319018 300690319018 MPN No. 31901 Only Lic.-Physician, Pharmacy, Dentist, Drug Mfg, Dist., Gov, Hospital, Lic.Lab, Naturalist, Naturopath, NP, Optometrist, Pharmacist, PA, Physical Therapist, Podiatrist, Research Co., Uni., VA, Vet & Wholesalers In Scope Of their Practice Can Order Rx Item. Other Name: Humira, Adalimuma

Have a question?

  Out of stock, please email us with the item number or product link at [email protected] for the quantity available, current pricing and eligibility to purchase.

ABRILADA� (adalimumab-afzb) is supplied as a preservative-free, sterile, clear and colorless to very light
brown solution for subcutaneous administration. The following packaging configurations are available.
� ABRILADA Pen Carton - 40 mg/0.8 mL
ABRILADA (adalimumab-afzb) injection is supplied in a carton containing two alcohol preps and two
single-dose pens. Each single-dose pen contains a 1 mL prefilled glass syringe with a fixed thin wall,
� inch needle, providing 40 mg/0.8 mL of ABRILADA. The needle cover is not made with natural
rubber latex.
The NDC number is 0069-0325-02.
� Prefilled Syringe Carton - 40 mg/0.8 mL (One Count)
ABRILADA is supplied in a carton containing two alcohol preps and one dose tray. The dose tray
consists of a single-dose, 1 mL prefilled glass syringe with a fixed thin wall, � inch needle, providing
40 mg/0.8 mL of ABRILADA. The needle cover is not made with natural rubber latex.
The NDC number is 0069-0328-01.
� Prefilled Syringe Carton - 40 mg/0.8 mL (Two Counts)
ABRILADA is supplied in a carton containing two alcohol preps and two dose trays. Each dose tray
consists of a single-dose, 1 mL prefilled glass syringe with a fixed thin wall, � inch needle, providing
40 mg/0.8 mL of ABRILADA. The needle cover is not made with natural rubber latex.
The NDC number is 0069-0328-02.
� Prefilled Syringe Carton - 20 mg/0.4 mL
ABRILADA is supplied in a carton containing two alcohol preps and two dose trays. Each dose tray
consists of a single-dose, 1 mL prefilled glass syringe with a fixed thin wall, � inch needle, providing
20 mg/0.4 mL of ABRILADA. The needle cover is not made with natural rubber latex.
The NDC number is 0069-0333-02.
� Prefilled Syringe Carton - 10 mg/0.2 mL
ABRILADA is supplied in a carton containing two alcohol preps and two dose trays. Each dose tray
consists of a single-dose, 1 mL prefilled glass syringe with a fixed thin wall, � inch needle, providing
10 mg/0.2 mL of ABRILADA. The needle cover is not made with natural rubber latex.
The NDC number is 0069-0347-02.
� Single-Dose Institutional Use Vial Carton - 40 mg/0.8 mL
ABRILADA is supplied for institutional use only in a carton containing a single-dose, glass vial,
providing 40 mg/0.8 mL of ABRILADA. The vial stopper is not made with natural rubber latex.
The NDC number is 0069-0319-01.
Storage and Stability
Do not use beyond the expiration date on the container. ABRILADA must be refrigerated at 36�F to 46�F (2�C
to 8�C). DO NOT FREEZE. Do not use if frozen even if it has been thawed. HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ABRILADA safely and effectively. See full prescribing information for ABRILADA. ABRILADA� (adalimumab-afzb) injection, for subcutaneous use Initial U.S. Approval: 2019 ABRILADA (adalimumab-afzb) is biosimilar* to HUMIRA (adalimumab). WARNING: SERIOUS INFECTIONS and MALIGNANCY See full prescribing information for complete boxed warning. SERIOUS INFECTIONS (5.1, 6.1): � Increased risk of serious infections leading to hospitalization or death, including tuberculosis (TB), bacterial sepsis, invasive fungal infections (such as histoplasmosis), and infections due to other opportunistic pathogens. � Discontinue ABRILADA if a patient develops a serious infection or sepsis during treatment. � Perform test for latent TB; if positive, start treatment for TB prior to starting ABRILADA. � Monitor all patients for active TB during treatment, even if initial latent TB test is negative. MALIGNANCY (5.2): � Lymphoma and other malignancies, some fatal, have been reported in children and adolescent patients treated with TNF blockers including adalimumab products. � Post-marketing cases of hepatosplenic T-cell lymphoma (HSTCL), a rare type of T-cell lymphoma, have occurred in adolescent and young adults with inflammatory bowel disease treated with TNF blockers including adalimumab products. --------------------------- INDICATIONS AND USAGE ---------------------------- ABRILADA is a tumor necrosis factor (TNF) blocker indicated for treatment of: � Rheumatoid Arthritis (RA) (1.1): Reducing signs and symptoms, inducing major clinical response, inhibiting the progression of structural damage, and improving physical function in adult patients with moderately to severely active RA. � Juvenile Idiopathic Arthritis (JIA) (1.2): Reducing signs and symptoms of moderately to severely active polyarticular JIA in patients 4 years of age and older. � Psoriatic Arthritis (PsA) (1.3): Reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in adult patients with active PsA. � Ankylosing Spondylitis (AS) (1.4): Reducing signs and symptoms in adult patients with active AS. � Adult Crohn�s Disease (CD) (1.5): Reducing signs and symptoms and inducing and maintaining clinical remission in adult patients with moderately to severely active Crohn�s disease who have had an inadequate response to conventional therapy. Reducing signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are intolerant to infliximab products. � Ulcerative Colitis (UC) (1.6): Inducing and sustaining clinical remission in adult patients with moderately to severely active ulcerative colitis who have had an inadequate response to immunosuppressants such as corticosteroids, azathioprine or 6-mercaptopurine (6-MP). The effectiveness of adalimumab products has not been established in patients who have lost response to or were intolerant to TNF blockers. � Plaque Psoriasis (Ps) (1.7): The treatment of adult patients with moderate to severe chronic plaque psoriasis who are candidates for systemic therapy or phototherapy, and when other systemic therapies are medically less appropriate. ----------------------- DOSAGE AND ADMINISTRATION ----------------------- � Administered by subcutaneous injection (2) Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis (2.1): � 40 mg every other week. � Some patients with RA not receiving methotrexate may benefit from increasing the frequency to 40 mg every week. Juvenile Idiopathic Arthritis (2.2): � 10 kg (22 lbs) to

RX00069-0319-01
Rx Item-Abrilada (adalimumab-afzb) Injec
RX00069-0319-01

Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.
Rx Item-Abrilada (adalimumab-afzb) Injec
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.

Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop
AmericanPharmaWholesale.com
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop